Welcome to visitShengming Biotechnology (Zhengzhou) Co., Ltd.!
NEWS

Working on CDMO for Macromolecular Target Drugs

Home > NEWS
What is the company's vision?
Time:2022-07-20  Click:212

Through the in-depth connection of the entire industrial chain from pre clinical research, clinical trials to commercial product production, it provides innovative process research and development and production services for enterprises, and replaces pure capacity output with high value-added technology output.